Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.

Emerging Research Fronts Comments

Return to menu of Emerging Research Fronts

ESI Special Topics, April 2006
Citing URL: http://www.esi-topics.com/erf/2006/april06-AndreaCerutti.html

From •>>April 2006

Andrea Cerutti answers a few questions about this month's emerging research front in field of Immunology:

Immunology
Article: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
Authors: Litinskiy, MB;Nardelli, B;Hilbert, DM;He, B;Schaffer, A;Casali, P;Cerutti, A
Journal: NAT IMMUNOL 142 2002, 3 (9): 822-829 SEP 2002
Addresses:
Cornell Univ, Div Mol Immunol, Dept Pathol & Lab Med, Joan & Sanford L Weill Med Coll, 1300 York Ave, New York, NY 10021 USA.
Cornell Univ, Div Mol Immunol, Dept Pathol & Lab Med, Joan & Sanford L Weill Med Coll, New York, NY 10021 USA.
Human Genome Sci, Rockville, MD 20850 USA.


ST:  Why do you think your paper is highly cited?


“Our paper describes an alternative pathway for the production of IgG, IgA and IgE antibodies...”

By substituting immunoglobulin (Ig) M with IgG, IgA, or IgE, class switching diversifies the effector functions of antibodies produced by mature B cells, thereby facilitating the clearance of invading microorganisms by the immune system. Class switching is thought to be highly dependent upon activation of B cells by CD4+ T cells, a cell type that orchestrates cellular and humoral immune responses by providing help to T cells and B cells, respectively.

Our paper shows for the first time that B cells can undergo CD40-independent class switching upon activation by CD40L-like factors produced by dendritic cells. These immune cells are distributed as sentinels throughout our body and initiate immune responses by capturing microbial products and presenting them to CD4+ T cells. Our findings indicate that dendritic cells have a hitherto unsuspected flexibility as they can initiate IgG, IgA, and IgE responses by activating B cells in a T cell-independent fashion.

ST:  Does it describe a new discovery or a new methodology that's useful to others?

Our paper describes an alternative pathway for the production of IgG, IgA, and IgE antibodies, which are essential for the clearance of microorganisms and their products both systemically and at portal sites of entry, including respiratory, intestinal, and urogenital mucosal surfaces. In addition to furthering our understanding of antibody responses against infectious agents, our research may help in elucidating antibody-mediated autoimmune disorders, such as lupus and rheumatoid arthritis.

ST:  Could you summarize the significance of your paper in layman's terms?

Our findings provide a novel mechanistic explanation for previously published studies indicating that B cells lodged within mucosal surfaces can produce IgG, IgA, and IgE antibodies in the absence of CD4+ T cell help. Unlike T cell-dependent antibody responses, which require five to seven days, T cell-independent antibody responses require only one to three days, thereby enabling the immune system to control infections at a very early time point. Thus, our observations further our understanding of a key immune process.

ST:  How did you become involved in this research, and were there successes or failures along the way?

I have a long-standing interest in the regulation of Ig heavy chain class switching and I have always been puzzled by the mechanisms underlying front line T cell-independent IgG, IgA, and IgE responses. Data published by other investigators showing dendritic cell production of powerful B cell-activating factors made me hypothesize the involvement of dendritic cells in the initiation of class switching during "front line" B cell responses. Compared to other projects previously developed in our lab, this was a relatively straightforward research endeavor.

ST:  If applicable, what are the social or political implications of your research?

Although conferring greater flexibility to B cells, the T cell-independent pathway described in our paper may have an autoimmune downside, as class switch-inducing factors produced by dendritic cells are implicated in lupus and rheumatoid arthritis, two relatively frequent autoimmune disorders characterized by production of IgG and IgA with abnormal reactivity against certain components of our own body.

By showing that certain compounds are capable of blocking dendritic cell-induced IgG and IgA production, our findings outline a novel therapeutic strategy that may help in reducing the social costs associated with antibody-mediated autoimmune disorders.End

Andrea Cerutti, M.D.
Assistant Professor
Pathology and Laboratory Medicine
Graduate Program in Immunology & Microbial Pathogenesis
Weill Medical College of Cornell University
New York, NY, USA

Return to Emerging Research Fronts | Return to Special Topics main menu
 

ESI Special Topics, April 2006
Citing URL: http://www.esi-topics.com/erf/2006/april06-AndreaCerutti.html

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.